Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200850 · ClinicalTrials.gov registry record · NA
Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT00200850 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 31 participants.
The verdict
NCT00200850, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This study will investigate sublingual immunotherapy (SLIT), a treatment involving antigens placement under the tongue to help asthma sufferers build a tolerance to the allergy-causing substances. Specifically, this study will determine the effectiveness of SLIT at two different dosing regimens for patients with intermittent mild asthma caused by dust mites.
Interventions
- BIOLOGICAL House Dust Mite SLIT
- BIOLOGICAL High dose SLIT
- BIOLOGICAL Placebo SLIT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00200850
The ClinicalTrials.gov registry entry for NCT00200850 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which House Dust Mite SLIT is the first listed.
NCT00200850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00200850 about?
NCT00200850 is a clinical study titled "Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy". This study will investigate sublingual immunotherapy (SLIT), a treatment involving antigens placement under the tongue to help asthma sufferers build a tolerance to the allergy-causing substances. Specifically, this study will determine the effectiveness of SLIT at two different dosing regimens for ...
What is the current status of trial NCT00200850?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2006-01. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00200850?
The interventions under investigation include: House Dust Mite SLIT (BIOLOGICAL), High dose SLIT (BIOLOGICAL), Placebo SLIT (BIOLOGICAL).
Who is sponsoring clinical trial NCT00200850?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.